SCHEMBL20705648

SCHEMBL20705648

Cc1ccc(C2=Cc3cc4c(cc3C2)Cc2cc3c(cc2C4=O)C=C(c2ccc(C)cc2)C3)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 2/20 0.41
MAOA P21397 2/20 0.33
NPC1 O15118 1/20 0.33
HPGDS O60760 1/20 0.33
TP53 P04637 1/20 0.33
PKM P14618 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
AGTR1 P30556 1/20 0.33
RAB9A P51151 1/20 0.33
MAOB P27338 1/20 0.33
PARP1 P09874 1/20 0.33
PARP10 Q53GL7 1/20 0.33
IP6K1 Q92551 1/20 0.33
IP6K3 Q96PC2 1/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
CYP11B1 P15538 2/20 0.32
CYP11B2 P19099 2/20 0.32
CYP19A1 P11511 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18328884 0.80 TDP2 (0.37) NPC1RAB9APARP1PARP10ESR1
SCHEMBL18328888 0.78 ESR1 (0.40) PARP1PARP10ESR1ESR2CYP11B1
SCHEMBL6939165 0.77 CYP11B1 (0.33) IP6K1IP6K3ESR1ESR2CYP11B1
SCHEMBL18328889 0.75 TDP2 (0.38) PARP1PARP10ESR1ESR2CYP11B1
SCHEMBL2627018 0.73 ALDH1A1 (0.32) TSHRCYP11B1CYP11B2CYP19A1
SCHEMBL12259134 0.73 ALDH1A1 (0.44) NPC1RAB9ACYP11B1CYP11B2CYP19A1
SCHEMBL6056983 0.71 METAP1 (0.67) METAP1MAOAMAOBPARP1PARP10
SCHEMBL1609651 0.70 METAP1 (0.71) METAP1MAOAMAOBPARP1PARP10
SCHEMBL6287169 0.70 CYP11B1 (0.54) MAOANPC1TP53PKMRAB9A
SCHEMBL30487694 0.70 CYP11B1 (0.54) MAOANPC1TP53PKMRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10195213-B2 Chemical entities that kill senescent cells for use in treating age-related disease UNITY BIOTECHNOLOGY, INC. (US) 2019-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10195213-B2 Chemical entities that kill senescent cells for use in treating age-related disease TP53, CDKN1A, GLA METAP1 2980/4885MAOA 1995/4885NPC1 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.